Accuray Return on Tangible Equity 2010-2025 | ARAY
Current and historical return on tangible equity values for Accuray (ARAY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Accuray Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.00B | $-0.01B | -9.09% |
| 2024-12-31 | $0.00B | $-0.01B | 30.19% |
| 2024-09-30 | $-0.02B | $-0.01B | 128.30% |
| 2024-06-30 | $-0.02B | $-0.01B | 136.17% |
| 2024-03-31 | $-0.02B | $-0.02B | 231.58% |
| 2023-12-31 | $-0.02B | $-0.01B | 250.00% |
| 2023-09-30 | $-0.01B | $-0.01B | 140.00% |
| 2023-06-30 | $-0.01B | $0.00B | 150.00% |
| 2023-03-31 | $-0.01B | $0.00B | 144.00% |
| 2022-12-31 | $-0.01B | $-0.01B | 151.72% |
| 2022-09-30 | $-0.01B | $-0.01B | 120.00% |
| 2022-06-30 | $-0.01B | $-0.01B | 62.50% |
| 2022-03-31 | $-0.01B | $-0.01B | 305.88% |
| 2021-12-31 | $-0.01B | $-0.01B | -480.00% |
| 2021-09-30 | $-0.01B | $-0.01B | -77.78% |
| 2021-06-30 | $-0.01B | $0.01B | -41.38% |
| 2021-03-31 | $0.01B | $0.02B | 37.74% |
| 2020-12-31 | $0.01B | $0.02B | 94.12% |
| 2020-09-30 | $0.01B | $0.01B | 430.77% |
| 2020-06-30 | $0.01B | $0.01B | -153.85% |
| 2020-03-31 | $0.00B | $0.00B | -59.26% |
| 2019-12-31 | $0.00B | $0.00B | 0.00% |
| 2019-09-30 | $-0.02B | $-0.02B | 130.61% |
| 2019-06-30 | $-0.02B | $-0.01B | 148.84% |
| 2019-03-31 | $-0.02B | $-0.01B | 145.45% |
| 2018-12-31 | $-0.02B | $-0.01B | 204.26% |
| 2018-09-30 | $-0.02B | $-0.01B | 213.33% |
| 2018-06-30 | $-0.02B | $-0.01B | 218.18% |
| 2018-03-31 | $-0.03B | $-0.01B | 243.48% |
| 2017-12-31 | $-0.02B | $-0.01B | 208.70% |
| 2017-09-30 | $-0.03B | $-0.01B | 219.61% |
| 2017-06-30 | $-0.03B | $-0.01B | 227.45% |
| 2017-03-31 | $-0.03B | $-0.01B | 275.56% |
| 2016-12-31 | $-0.03B | $-0.02B | 277.78% |
| 2016-09-30 | $-0.02B | $-0.01B | 293.33% |
| 2016-06-30 | $-0.03B | $-0.01B | 370.37% |
| 2016-03-31 | $-0.02B | $-0.01B | 505.26% |
| 2015-12-31 | $-0.03B | $-0.01B | 861.54% |
| 2015-09-30 | $-0.03B | $-0.01B | 2133.33% |
| 2015-06-30 | $-0.04B | $0.00B | -8200.00% |
| 2015-03-31 | $-0.05B | $0.00B | -1058.82% |
| 2014-12-31 | $-0.05B | $0.00B | -671.43% |
| 2014-09-30 | $-0.04B | $0.00B | -420.00% |
| 2014-06-30 | $-0.04B | $0.02B | -313.04% |
| 2014-03-31 | $-0.05B | $0.01B | -400.00% |
| 2013-12-31 | $-0.07B | $0.01B | -458.06% |
| 2013-09-30 | $-0.10B | $0.01B | -355.14% |
| 2013-06-30 | $-0.10B | $0.02B | -240.94% |
| 2013-03-31 | $-0.10B | $0.03B | -166.40% |
| 2012-12-31 | $-0.09B | $0.06B | -107.32% |
| 2012-09-30 | $-0.07B | $0.07B | -70.77% |
| 2012-06-30 | $-0.07B | $0.10B | -65.45% |
| 2012-03-31 | $-0.08B | $0.11B | -66.24% |
| 2011-12-31 | $-0.06B | $0.12B | -47.28% |
| 2011-09-30 | $-0.05B | $0.12B | -33.28% |
| 2011-06-30 | $-0.03B | $0.12B | -17.09% |
| 2011-03-31 | $0.00B | $0.18B | 1.77% |
| 2010-12-31 | $0.01B | $0.17B | 3.64% |
| 2010-09-30 | $0.00B | $0.16B | 0.63% |
| 2010-06-30 | $0.00B | $0.17B | 1.92% |
| 2010-03-31 | $0.00B | $0.16B | -0.66% |
| 2009-12-31 | $0.00B | $0.15B | -1.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.182B | $0.459B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.101B | 22.27 |
| Intuitive Surgical (ISRG) | United States | $172.528B | 71.51 |
| IDEXX Laboratories (IDXX) | United States | $51.032B | 53.11 |
| Edwards Lifesciences (EW) | United States | $45.970B | 30.47 |
| Alcon (ALC) | Switzerland | $43.470B | 29.38 |
| IQVIA Holdings (IQV) | United States | $32.732B | 18.50 |
| DexCom (DXCM) | United States | $31.694B | 47.54 |
| Mettler-Toledo (MTD) | United States | $27.012B | 32.06 |
| STERIS (STE) | Ireland | $24.087B | 25.64 |
| Waters (WAT) | United States | $17.226B | 23.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.782B | 0.00 |
| Hologic (HOLX) | United States | $14.962B | 16.21 |
| Penumbra (PEN) | United States | $9.958B | 72.75 |
| Sysmex ADR (SSMXY) | Japan | $8.391B | 26.66 |
| Masimo (MASI) | United States | $8.362B | 28.14 |
| Globus Medical (GMED) | United States | $8.137B | 18.77 |
| Teleflex (TFX) | United States | $5.297B | 8.55 |
| Glaukos (GKOS) | United States | $5.134B | 0.00 |
| TransMedics (TMDX) | United States | $4.283B | 65.10 |
| Integer Holdings (ITGR) | United States | $3.698B | 18.45 |
| LivaNova (LIVN) | United Kingdom | $2.909B | 16.65 |
| Veracyte (VCYT) | United States | $2.366B | 32.69 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.265B | 0.00 |
| Artivion (AORT) | United States | $2.022B | 102.02 |
| Nihon Kohden (NHNKY) | Japan | $1.999B | 23.86 |
| Elekta AB (EKTAY) | Sweden | $1.847B | 17.28 |
| OPKO Health (OPK) | United States | $1.111B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.095B | 6.27 |
| Pulse Biosciences (PLSE) | United States | $1.055B | 0.00 |
| IRadimed (IRMD) | United States | $0.892B | 43.28 |
| Beta Bionics (BBNX) | United States | $0.750B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.732B | 0.00 |
| AxoGen (AXGN) | United States | $0.713B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.522B | 9.22 |
| Semler Scientific (SMLR) | United States | $0.500B | 4.01 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.376B | 9.57 |
| Delcath Systems (DCTH) | United States | $0.373B | 88.75 |
| AngioDynamics (ANGO) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.35 |
| NeuroPace (NPCE) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.232B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.204B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| CVRx (CVRX) | United States | $0.180B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.116B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.096B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.076B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 20.89 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |